[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
February 24, 1984

Introduction of Sodium Diphenyl Hydantoinate

Author Affiliations

From the Department of Neurology, College of Medicine, University of Iowa Hopitals, Iowa City.

JAMA. 1984;251(8):1068-1069. doi:10.1001/jama.1984.03340320054028
Abstract

Had the discovery of the anticonvulsant properties of sodium diphenyl hydantoinate been fortuitous, an article first reporting the effectiveness of this drug in man would justify its inclusion as a landmark article in the centennial celebration issues of JAMA. This drug, now called phenytoin (Dilantin), soon revolutionized the drug treatment of the convulsive disorders when such treatment had been largely limited to the bromides and phenobarbital. Phenytoin remains today a mainstay of therapy in the control of major motor seizures and some other manifestations of epilepsy. Few drugs continue in active use in unmodified form 45 years after the discovery of their usefulness. Few drugs have been as important for the relief of human disability and suffering, and this with an acceptable level of side and toxic effects in most patients.

That phenytoin was chosen by logical inference to be included in a series of drugs actively tested for effectiveness

References
1.
Merritt HH, Putnam TJ:  Sodium diphenyl hydantoinate in the treatment of convulsive disorders .  JAMA 1938;111:1068-1073.Crossref
2.
Putnam TJ, Merritt HH:  Experimental determination of the anticonvulsant properties of some phenyl derivatives .  Science 1937;85:525-526.Crossref
3.
Harrison TR, Mason MF, Resnik H:  Observations on the mechanism of muscular twitchings in uremia .  J Clin Invest 1936;15:463-464.
4.
Merritt HH, Putnam TJ:  A new series of anticonvulsant drugs tested by experiments on animals .  Arch Neurol Psychiatry 1938;39:1003-1015.Crossref
5.
Merritt HH, Putnam TJ:  Further experiences with the use of sodium diphenyl hydantoinate in the treatment of convulsive disorders .  Am J Psychiatry 1940;96:1023-1027.
6.
Merritt HH, Putnam TJ:  Sodium diphenyl hydantoinate in the treatment of convulsive seizures: Toxic symptoms and their prevention .  Arch Neurol Psychiatry 1939;45:1053-1058.Crossref
7.
Gibbs FA, Gibbs EL, Lennox WG:  Cerebral dysrhythymias of epilepsy .  Arch Neurol Psychiatry 1938;39:298-314.Crossref
8.
Merritt HH:  Tracy Jackson Putnam 1894-1975 .  Trans Am Neurol Assoc 1975;100:271-272.
9.
Rowland LP:  First annual Merritt-Putnam symposium: Introduction .  Epilepsia 1982;23( (suppl 1) ):1-4.Crossref
×